Fiona 60 Mg Tablet (Raloxifene)

Required

United States dollar ($) - USD
  • United States dollar ($) - USD
  • Euro (€) - EUR
  • Canadian dollar ($) - CAD

Add $199.00 to cart and get free shipping!

15 People watching this product now!
Written by Dr Ambrose Chan, MD, MD Medically reviewed by Dr. Sabrina Castillon, MD, MD
Last updated on September 29, 2026
Description

About Fiona 60 Mg Tablet (Raloxifene)

Medicine information

Active ingredient
Raloxifene
Delivery time
10–14 business days after dispatch for the United States, United Kingdom, Canada, and Australia; 12–18 business days for Europe; 14–21 business days for the Middle East and other served destinations. These are estimated transit times and customs or local carrier delays may extend delivery. Cheap_Generic_Med_Shipping_Coun…
Indication
Treatment and prevention of osteoporosis in postmenopausal women. Raloxifene is also indicated to reduce the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk of invasive breast cancer. It is not a treatment for existing invasive breast cancer and is not indicated to reduce breast-cancer recurrence.
Manufacturer
Dr. Reddy's Laboratories Ltd.
Packaging
Strip of 10 tablets.
Strength
60 mg
Dosage form
Tablet
Route
Oral

Medicine overview

Fiona 60 Mg Tablet contains raloxifene, a selective estrogen receptor modulator (SERM). It is used mainly to prevent and treat osteoporosis in postmenopausal women. Raloxifene acts like estrogen in bone, helping reduce the increased bone breakdown that can occur after menopause. It also blocks certain estrogen effects in breast tissue and is used to reduce the risk of invasive breast cancer in specific groups of postmenopausal women. Fiona is an oral prescription tablet manufactured by Dr. Reddy's Laboratories Ltd.

What it is used for

Fiona 60 Mg Tablet is used to prevent and treat osteoporosis after menopause, when declining estrogen levels can accelerate bone loss and increase fracture risk. Raloxifene can also reduce the risk of invasive breast cancer in postmenopausal women who have osteoporosis or are otherwise considered at high risk for invasive breast cancer. It does not treat established breast cancer and has not been shown to prevent recurrence of previously diagnosed invasive breast cancer.

How it works

Raloxifene is a selective estrogen receptor modulator, meaning its effects differ between tissues. In bone, it acts partly like estrogen and reduces bone resorption, or the process in which old bone is broken down. This helps maintain bone mineral density and reduces fracture risk associated with postmenopausal osteoporosis. In breast tissue, raloxifene blocks estrogen-related activity, which explains its role in reducing the risk of certain invasive breast cancers in appropriately selected postmenopausal women.

How it is taken

Raloxifene 60 mg is taken by mouth. The verified prescribing information specifies one 60 mg tablet once daily, and it may be taken at any time of day with or without food. Taking it at about the same time each day may make it easier to remember. If dietary calcium or vitamin D intake is inadequate during osteoporosis treatment or prevention, supplementation may be advised by the treating healthcare professional. Do not take two doses together to compensate for a missed dose.

Important warnings

Raloxifene increases the risk of venous thromboembolism, including deep-vein thrombosis and pulmonary embolism, and must not be used in women with an active or previous venous thromboembolism, including retinal vein thrombosis. It should be stopped at least 72 hours before and during prolonged immobilization, such as recovery after surgery or prolonged bed rest, and movement is advised during long journeys. In postmenopausal women with documented coronary heart disease or increased coronary risk, a clinical trial found an increased risk of death due to stroke; individual stroke risk therefore requires medical assessment. Raloxifene should not be used to prevent cardiovascular disease. Use is not recommended in premenopausal women or with systemic estrogen therapy, and caution is required with hepatic or moderate-to-severe renal impairment. Cholestyramine and similar anion-exchange resins can substantially reduce raloxifene absorption. Patients taking warfarin require closer prothrombin-time monitoring when raloxifene is started or stopped. Seek urgent medical attention for unexplained leg pain, warmth or swelling, sudden chest pain, shortness of breath, coughing blood, or sudden vision changes.

Side effects and monitoring

Common adverse effects include hot flashes, leg cramps or muscle spasms, swelling of the hands or feet (peripheral edema), flu-like symptoms, joint pain, and increased sweating. Serious concerns include deep-vein thrombosis, pulmonary embolism and, rarely, retinal vein occlusion; stroke and deaths associated with venous thromboembolism have also been reported after marketing. Urgent assessment is needed for one-sided leg swelling or pain, sudden chest pain, difficulty breathing, coughing blood, or sudden changes in vision. Women using raloxifene for breast-cancer risk reduction should continue appropriate breast examinations and mammography. Prothrombin time should be monitored more closely when raloxifene is started or stopped in patients taking warfarin; serum triglyceride monitoring is advised when previous estrogen therapy caused hypertriglyceridemia.

Pregnancy

Raloxifene is contraindicated during pregnancy and is not indicated for women of reproductive potential. Its mechanism may interfere with estrogen functions that are important during pregnancy, and animal studies found adverse reproductive and developmental effects.

Breastfeeding

Raloxifene is not indicated for women of reproductive potential. There are no adequate data on whether raloxifene passes into human milk, affects a breastfed child, or changes milk production. Based on its mechanism, it may interfere with estrogen functions in breast tissue during lactation.

Food, drink and interactions

No specific direct raloxifene–alcohol interaction is established in the verified prescribing information. For osteoporosis management, excessive alcohol consumption should be reduced because it is a modifiable factor affecting bone health.

Food and drink

Raloxifene may be taken with or without food. Although a high-fat meal can modestly increase absorption, this does not produce a clinically meaningful change in exposure, so meal timing is not required. Adequate calcium and vitamin D intake is important during osteoporosis prevention or treatment, and supplements may be recommended when dietary intake is insufficient.

Storage

Store below 30°C. Keep the medicine appropriately protected and out of the reach of children. Product listings for Fiona specify storage below 30°C.

Frequently asked questions

Can raloxifene make hot flashes worse?

Yes. Hot flashes are a recognized side effect of raloxifene, particularly after treatment begins. Raloxifene does not treat menopausal hot flashes and may cause them in some women who did not previously have them.

Why do I need to worry about blood clots while taking raloxifene?

Raloxifene increases the risk of venous blood clots, including deep-vein thrombosis and pulmonary embolism. Seek urgent medical attention for unexplained leg swelling or pain, sudden chest pain, shortness of breath, coughing blood, or sudden vision changes.

Do I need to stop raloxifene before surgery or a period of bed rest?

Yes, when prolonged immobilization is expected. The prescribing information states that raloxifene should be discontinued at least 72 hours before and during prolonged immobilization and resumed only after the patient is fully mobile, under medical guidance.

Can I take raloxifene with calcium and vitamin D?

Yes. Calcium and vitamin D can be taken at the same time as raloxifene, and adequate intake is important when raloxifene is being used for osteoporosis. Your healthcare professional can advise whether supplementation is needed.

Does raloxifene prevent all types of breast cancer?

No. Raloxifene is indicated to reduce the risk of invasive breast cancer in certain postmenopausal women, but it is not indicated to treat invasive breast cancer, prevent its recurrence, or reduce the risk of noninvasive breast cancer.

Can Fiona 60 Mg Tablet be taken with food?

Yes. Raloxifene may be taken with or without food, and it can be taken at any time of day. Taking it at approximately the same time each day can help with consistent use.

What happens if I miss a raloxifene dose?

Take the missed dose when you remember unless it is almost time for the next dose. In that case, skip the missed dose and continue with the next scheduled dose; do not take two doses together.

Can Cheap Generic Med ship Fiona 60 Mg Tablet to the United States?

Cheap Generic Med serves the United States under its international shipping model. Delivery is typically estimated at 10–14 business days after dispatch, but customs or carrier delays can extend transit, and prescription or personal-import requirements may apply.

Will my Cheap Generic Med order have tracking?

Under the standard international fulfilment model, tracked shipping is used and a tracking number should be provided after dispatch. New tracking details may take 24–72 hours to show movement in the carrier system.

Sources

  1. dailymed.nlm.nih.gov
  2. medlineplus.gov
  3. www.cancer.gov
  4. www.1mg.com

Medical information notice: This information does not replace advice from a qualified healthcare professional. Use prescription medicine only as directed by the prescriber and the approved product information.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Fiona 60 Mg Tablet (Raloxifene)”

Your email address will not be published. Required fields are marked *